RSS Feed for This PostCurrent Article

Eli Lilly stock: Hurt by patent loss

With patent expirations on the horizon and health-care policy in flux, should investors consider a dose of Eli Lilly?

Original post by Technology news - Business 2.0 Magazine

Trackback URL

You must be logged in to post a comment.

Free E-business E-Book from RevenueTip.com!

*  Your Name:
*  Your E-mail: